Home / Feed item / OIRM: Randomization and blinding can change the results of a study and need to be considered in pre-clinical design #bench2bed
OIRM: Randomization and blinding can change the results of a study and need to be considered in pre-clinical design #bench2bed
Our Vision
OIRM will transform the treatment of incurable diseases, making Ontario a global leader in the development and dissemination and dissemination of stem cell-based products and therapies.
